|
(1S)-1-环丙基乙-1-胺盐酸盐
|
S175013-1g
|
≥97% |
178033-78-8 |
1g
|
¥ 177.9
|
现货 |
|
0 |
阿拉丁 |
|
螺[2.2]戊烷-1-羧酸
|
S174950-100mg
|
≥97% |
17202-64-1 |
100mg
|
¥ 369.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
螺[2.3]己烷-1-羧酸
|
S174949-1g
|
≥97% |
17202-56-1 |
1g
|
¥ 1295.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3S,5S)-1-苄基-3,5-二甲基哌嗪-2-酮
|
S174929-250mg
|
≥97% |
170211-02-6 |
250mg
|
¥ 3502.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(3-甲氧基吡啶-2-基)乙酸钠
|
S174856-1g
|
≥97% |
1643136-45-1 |
1g
|
¥ 3237.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4S)-4-氨基-3,3-二甲基-1-[[(1R)-1-苯基乙基]吡咯烷-2-酮
|
S174812-100mg
|
≥97% |
1638763-93-5 |
100mg
|
¥ 5954.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4S)-4-(氨基甲基)吡咯烷-2-酮盐酸盐
|
S174787-250mg
|
≥97% |
1638744-96-3 |
250mg
|
¥ 3222.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S)-2,2-二氟环己-1-胺盐酸盐
|
S174781-250mg
|
≥97% |
1638744-12-3 |
250mg
|
¥ 10261.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(4S)-4-氨基-3,3-二甲基吡咯烷-2-酮
|
S174779-100mg
|
≥97% |
1638743-93-7 |
100mg
|
¥ 4903.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S)-1-[5-(1-甲基-4-{4-[(3-甲基吡啶-2-基)] [(3R)-哌啶-3-基]氨基甲酰基]苯基} -1H-吡唑-5 -基)-2H-1,2,3,4-四唑-2-基] 2-甲基丙酸乙酯
|
S174767-100mg
|
≥97% |
1632250-94-2 |
100mg
|
¥ 17510.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-氯-[1,2,4]三唑并[4,3-b]哒嗪-3-羧酸钠
|
S174699-1g
|
≥97% |
1630906-50-1 |
1g
|
¥ 2509.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,4S)-2-乙基-2,5-二氮杂双环[2.2.1]庚烷二氢溴化物
|
S174682-500mg
|
≥97% |
1630818-55-1 |
500mg
|
¥ 5779.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,3S)-3-氨基双环[2.2.2]辛烷-2-羧酸
|
S174642-1g
|
≥97% |
1621863-51-1 |
1g
|
¥ 9455.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
STS-E412,EPOR / CD131受体激活剂
|
S174607-100mg
|
≥97% |
1609980-39-3 |
100mg
|
¥ 4224.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-[(2S)-哌啶-2-基] -1-(2,3,4-三氟苯甲酰基)氮杂环丁烷-3-醇
|
S174590-250mg
|
≥97% |
1597407-59-4 |
250mg
|
¥ 4239.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,4S)-2,4-二氨基戊二酸二盐酸盐
|
S174578-1g
|
≥97% |
159206-44-7 |
1g
|
¥ 6056.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2s)-1-[[(叔丁氧基)羰基]氮杂环庚烷-2-羧酸
|
S174542-1g
|
≥97% |
155905-76-3 |
1g
|
¥ 2900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(哒嗪-4-基)乙酸钠
|
S174433-250mg
|
≥97% |
1523571-92-7 |
250mg
|
¥ 9911.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,5R)-1,2,5-三甲基哌嗪草酸盐
|
S174410-250mg
|
≥97% |
1523541-99-2 |
250mg
|
¥ 8510.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S)-1,4-二恶烷-2-基甲胺盐酸盐
|
S174408-1g
|
≥97% |
1523541-96-9 |
1g
|
¥ 123.9
|
现货 |
|
0 |
阿拉丁 |
|
[(2S)-2-甲基吡咯烷-2-基]甲醇盐酸盐
|
S174403-1g
|
≥97% |
1523541-78-7 |
1g
|
¥ 2047.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1S,4S)-2-氧杂-5-氮杂双环[2.2.1]庚烷半草酸酯
|
S174401-1g
|
≥97% |
1523541-76-5 |
1g
|
¥ 1505.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2S,6S)-2,6-二甲基哌嗪草酸酯
|
S174396-250mg
|
≥97% |
1523530-70-2 |
250mg
|
¥ 8755.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SAR-405,PIK3C3/Vps34抑制剂
|
S174388-100mg
|
Moligand™, ≥97% |
1523406-39-4 |
100mg
|
¥ 8999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |